Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2026)

Treace Medical Concepts' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• Quarterly Accumulated Expenses rose 15.18% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 15.18% YoY) and the FY2025 annual result came in at $5.8 million, down 12.03% from the prior year.
• Accumulated Expenses was $6.0 million for Q1 2026 at Treace Medical Concepts, up from $5.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $15.2 million in Q1 2024 and bottomed at $398000.0 in Q3 2023.
• A 5-year average of $5.0 million and a median of $5.2 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses slumped 94.56% — and 2025, when it jumped 1635.63%.
• Treace Medical Concepts' Accumulated Expenses stood at $7.7 million in 2022, then slumped by 94.56% to $417000.0 in 2023, then jumped by 1476.74% to $6.6 million in 2024, then fell by 12.03% to $5.8 million in 2025, then increased by 3.35% to $6.0 million in 2026.
• Business Quant data shows TMCI's Accumulated Expenses at $6.0 million in Q1 2026, $5.8 million in Q4 2025, and $413000.0 in Q3 2025.